In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Clinical Microbiology and Infectious Diseases Année : 2010

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints

Résumé

The aims of the study were to determine the activity of doripenem, a new carbapenem, against a large number of bacterial pathogens and to propose zone diameter breakpoints for clinical categorization in France according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) minimum inhibitory concentration (MIC) breakpoints. The MICs of doripenem were determined by the broth microdilution method against 1,547 clinical isolates from eight French hospitals. The disk diffusion test was performed (10-μg discs) according to the Comité de l'Antibiogramme de la Société Française de Microbiologie (CASFM) method. The MIC (mg/L) values were as follows: methicillin-susceptible (MSSA) (0.03/0.25), methicillin-resistant (MRSA) (1/2), methicillin-susceptible coagulase-negative staphylococci (MSCoNS) (0.03/0.12), methicillin-resistant coagulase-negative staphylococci (MRCoNS) (2/8), (0.016/0.25), viridans group streptococci (0.016/2), β-hemolytic streptococci (≤0.008/≤0.008), (2/4), (128/>128), (0.06/0.25), (0.5/8), (0.25/2), (0.12/0.25), and (0.03/0.06). According to the regression curve, the zone diameter breakpoints were 24 and 19 mm for MICs of 1 and 4 mg/L, respectively. This study confirms the potent activity of doripenem against , , , MSSA, MSCoNS, and respiratory pathogens. According to the EUCAST MIC breakpoints (mg/L) ≤1/>4 for , , and , and ≤1/>1 for streptococci, pneumococci, and , the zone diameter breakpoints could be (mm) ≥24/<19 and ≥24/<24, respectively.

Mots clés

Domaines

Bactériologie
Fichier principal
Vignette du fichier
PEER_stage2_10.1007%2Fs10096-010-1117-6.pdf (781.46 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-00642845 , version 1 (19-11-2011)

Identifiants

Citer

C. Lascols, P. Legrand, A. Mérens, R. Leclercq, L. Armand-Lefevre, et al.. In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints. European Journal of Clinical Microbiology and Infectious Diseases, 2010, 30 (4), pp.475-482. ⟨10.1007/s10096-010-1117-6⟩. ⟨hal-00642845⟩
223 Consultations
161 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More